Liming Shao

14PUBLICATIONS
15CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsOrganometallic chemistryCharacterisation of biological macromoleculesFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 29, 2026
Pharmacological Characterization of SLL-022CCP, a Selective κ‑Opioid Receptor Agonist with Potent Antinociceptive Effects and Low Central Side Effects.

|Jul 28, 2025
Structure-Activity Relationship of N-Cyclopropylmethyl-7α-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines as Potent and Selective Kappa Opioid Receptor Agonists.

Linghui Kong, Songyu Yao, Denggao Zhang

|Apr 22, 2024
Discovery of an Ortho-Substituted N-Cyclopropylmethyl-7α-phenyl-6,14-endoethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative Effect.

Zixiang Li, Rufeng Ye, Qian He

|Mar 12, 2024
Synthesis of easily-modified and useful dibenzo-[b,d]azepines by palladium(II)-catalyzed cyclization/addition with a green solvent.

Hua Cheng, Rongqi Liu, Shengyang Fang

|Aug 25, 2022
Discovery of Potent and Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Agonists with Analgesic Effects In Vivo Based on the Functional Conversion Induced by Altering the Orientation of the Indazole Core.

Qianqian Liang, Zhen Qiao, Qiqi Zhou

|Jul 28, 2022
SLL-627 Is a Highly Selective and Potent κ Opioid Receptor (KOR) Agonist with an Unexpected Nonreduction in Locomotor Activity.

Linghui Kong, Xuelian Shu, Siyuan Tang

Pageof 3

Frequent Collaborators

7 joint publications

Wei Fu

5 joint publications

Wei Li

4 joint publications

Linghui Kong

3 joint publications

Qiong Xie